Good afternoon, everyone, and thank you for joining us today. 2025 was a year of exceptional execution, one that proved the ...

The research introduces a novel memory architecture called MSA (Memory Sparse Attention). Through a combination of the Memory Sparse Attention mechanism, Document-wise RoPE for extreme context ...

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 Earnings Call Transcript March 12, 2026 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $-0.358.

Copper Creek drilling confirms porphyry mineralization as broad structurally controlled copper-gold mineralization in a historically drilled but under-tested target area approximately 2.5 km southeast ...

The amount of sleep a person needs depends on many factors, including age. Xywav is the only liquid medicine approved to treat both narcolepsy and idiopathic hypersomnia. which is safe and effective ...